<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00221897</url>
  </required_header>
  <id_info>
    <org_study_id>RO1-EY08208; RO1-EY11008</org_study_id>
    <nct_id>NCT00221897</nct_id>
  </id_info>
  <brief_title>Diagnostic Innovations in Glaucoma Study</brief_title>
  <acronym>DIGS</acronym>
  <official_title>Diagnostic Innovations in Glaucoma Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, longitudinal observational cohort study evaluating the relationship between
      changes in the structure of the eye and the vision loss caused by glaucoma. There are two
      main parts to the study: 1) Visual Function and 2) Optic Nerve Structure
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is:

        1. To further determine the nature of vision loss and optic nerve structural change
           associated with glaucoma. Using recently developed psychophysical and imaging
           techniques, we will continue use of a multivariate approach for analysis of the
           functional and structural changes associated with glaucoma to delineate further the
           relationship of these changes to the underlying physiological mechanisms associated with
           magnocellular, small bistratified &quot;blue-yellow&quot;, and parvocellular neural pathways.

        2. To evaluate and improve new diagnostic and monitoring techniques encompassing measures
           of visual function and optic nerve and retina nerve fiber layer structure and to compare
           the rate and patterns of progression of glaucomatous damage

        3. To improve techniques for evaluation of current management and new therapies for
           glaucoma as they become available. We will expand our analysis using multivariate
           techniques incorporating visual function, optic nerve structure, and various risk
           factors to improve detection of true change.

        4. To determine the quantitative temporal relationships between recognizable optic nerve
           damage and measurable visual field loss. Using new techniques with improved sensitivity,
           the detection and monitoring of early optic disc defects may provide profiles of people
           at risk for developing glaucomatous visual function loss thus better defining target
           populations for treatment.

      SPECIFIC AIMS OF DIGS: STRUCTURAL ASSESSMENT Overall Aim: Develop improved methods to 1)
      detect the onset and progression of structural damage due to glaucoma, and 2) to measure the
      rate of glaucomatous progression and its determinants, and 3) characterize the relationship
      between structural and functional change over time. In addition, a major goal of this
      research is to develop methods to shorten the time frame needed to identify and verify
      progression of optic disc and retinal nerve fiber damage.

      SPECIFIC AIMS OF DIGS: VISUAL FUNCTION Overall Aim: Develop improved measures to detect the
      onset and progression of glaucoma, to assess treatment effectiveness, and to validate
      predictive genetic testing using psychophysical measures of visual function.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 1995</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>Healthy individuals</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Persons at risk for or with primary open angle glaucoma</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Open angles

          -  Best-corrected acuity of 20/40 or better

          -  Spherical refraction within + 5.0 D, and cylinder within + 3.0 D with plus OR minus
             cylinders

          -  â‰¥ 18 years old

          -  A family history of glaucoma is allowed

          -  Ability for study to acquire adequate or better quality stereophotographs

          -  Ability to do reliable standard Humphrey 30-2 or 24-2 visual fields

          -  Participants with glaucoma or at risk for glaucoma or healthy controls

        Exclusion Criteria:

          -  History of intraocular surgery (except for uncomplicated cataract surgery)

          -  Non-glaucomatous secondary causes of elevated IOP (e.g. iridocyclitis, trauma)

          -  Other intraocular eye disease

          -  Other diseases affecting visual field (e.g. pituitary lesions, demyelinating diseases,
             HIV+ or AIDS, or diabetic retinopathy), with medications known to affect visual field
             sensitivity

          -  Problems other than glaucoma affecting color vision.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda Zangwill, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felipe Medeiros, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eunice Williams-Steppe, MA</last_name>
    <phone>858-822-1133</phone>
    <email>ewsteppe@glaucoma.ucsd.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cheryl Rudy-Goodness, MPH</last_name>
    <phone>858-822-1896</phone>
    <email>cgoodness@glaucoma.ucsd.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSD, Hamilton Glaucoma Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093-0946</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eunice Williams-Steppe, MA</last_name>
      <phone>858-822-1133</phone>
      <email>ewsteppe@glaucoma.ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Cecelia Gastelum, MPH</last_name>
      <phone>858-534-6714</phone>
      <email>cgastelum@glaucoma.ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Linda M Zangwill, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert N Weinreb, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Felipe Medeiros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Bowd, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Sample PA, Weinreb RN, Boynton RM. Acquired dyschromatopsia in glaucoma. Surv Ophthalmol. 1986 Jul-Aug;31(1):54-64. Review.</citation>
    <PMID>3529468</PMID>
  </results_reference>
  <results_reference>
    <citation>Weinreb R.N. and Greve E.L. (Eds.). (2004). Glaucoma diagnosis. Structure and function. The Hague, The Netherlands: Kugler Publications.</citation>
  </results_reference>
  <results_reference>
    <citation>Stamper R. L., Sample P. A. and Girkin C. A. (Eds.). (2003). Assessing Visual Function in Clinical Practice. Ophthalmology Clinics of North America, Vol.16, Number 2. In Anderson D.R.(ed.) Standard Perimetry (pp. 205-212).</citation>
  </results_reference>
  <results_reference>
    <citation>Stamper R. L., Sample P. A. and Girkin C. A. (Eds.). (2003). Assessing Visual Function in Clinical Practice. Ophthalmology Clinics of North America, Vol.16, Number 2. In Anderson J.A and Johnson C.A. (eds.). Frequency-Doubling Technology Perminetry (pp. 213-226)</citation>
  </results_reference>
  <results_reference>
    <citation>Stamper R. L., Sample P. A. and Girkin C. A. (Eds.). (2003). Assessing Visual Function in Clinical Practice. Ophthalmology Clinics of North America, Vol.16, Number 2. In Racette L and Sample P.A. (eds.). Short wave automated perimetry. (pp. 227 -236).</citation>
  </results_reference>
  <results_reference>
    <citation>Zangwill LM, Abunto T, Bowd C, Angeles R, Schanzlin DJ, Weinreb RN. Scanning laser polarimetry retinal nerve fiber layer thickness measurements after LASIK. Ophthalmology. 2005 Feb;112(2):200-7.</citation>
    <PMID>15691551</PMID>
  </results_reference>
  <results_reference>
    <citation>Medeiros FA, Zangwill LM, Bowd C, Vessani RM, Susanna R Jr, Weinreb RN. Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am J Ophthalmol. 2005 Jan;139(1):44-55.</citation>
    <PMID>15652827</PMID>
  </results_reference>
  <results_reference>
    <citation>Zangwill LM, Chan K, Bowd C, Hao J, Lee TW, Weinreb RN, Sejnowski TJ, Goldbaum MH. Heidelberg retina tomograph measurements of the optic disc and parapapillary retina for detecting glaucoma analyzed by machine learning classifiers. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3144-51.</citation>
    <PMID>15326133</PMID>
  </results_reference>
  <results_reference>
    <citation>Bowd C, Zangwill LM, Medeiros FA, Hao J, Chan K, Lee TW, Sejnowski TJ, Goldbaum MH, Sample PA, Crowston JG, Weinreb RN. Confocal scanning laser ophthalmoscopy classifiers and stereophotograph evaluation for prediction of visual field abnormalities in glaucoma-suspect eyes. Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2255-62.</citation>
    <PMID>15223803</PMID>
  </results_reference>
  <results_reference>
    <citation>Sample PA, Chan K, Boden C, Lee TW, Blumenthal EZ, Weinreb RN, Bernd A, Pascual J, Hao J, Sejnowski T, Goldbaum MH. Using unsupervised learning with variational bayesian mixture of factor analysis to identify patterns of glaucomatous visual field defects. Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2596-605.</citation>
    <PMID>15277482</PMID>
  </results_reference>
  <results_reference>
    <citation>Medeiros FA, Sample PA, Weinreb RN. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol. 2004 May;137(5):863-71.</citation>
    <PMID>15126151</PMID>
  </results_reference>
  <results_reference>
    <citation>Medeiros FA, Zangwill LM, Bowd C, Weinreb RN. Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and stratus OCT optical coherence tomograph for the detection of glaucoma. Arch Ophthalmol. 2004 Jun;122(6):827-37.</citation>
    <PMID>15197057</PMID>
  </results_reference>
  <results_reference>
    <citation>Mohammadi K, Bowd C, Weinreb RN, Medeiros FA, Sample PA, Zangwill LM. Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss. Am J Ophthalmol. 2004 Oct;138(4):592-601.</citation>
    <PMID>15488786</PMID>
  </results_reference>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>August 29, 2011</last_update_submitted>
  <last_update_submitted_qc>August 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2011</last_update_posted>
  <responsible_party>
    <name_title>Neeraj Agarwal/Program Officer</name_title>
    <organization>National Eye Institute</organization>
  </responsible_party>
  <keyword>Primary open angle glaucoma</keyword>
  <keyword>Glaucoma/pathology</keyword>
  <keyword>Glaucoma/physiopathology</keyword>
  <keyword>Nerve Fibers/pathology</keyword>
  <keyword>Risk factors glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

